Breaking News Instant updates and real-time market news.

2021-02-12 12:40:23 ACB Aurora Cannabis $13.54 / -0.89 (-6.17%) 12:40 02/12/21 02/12 12:40 02/12/21 12:40	Aurora Cannabis price target raised to C$14 from C$11 at Canaccord Canaccord analyst Matt Bottomley raised the firm's price target on Aurora Cannabis to C$14 from C$11 and keeps a Hold rating on the shares.	11 Nov 22 Jan
ACB Aurora Cannabis $13.54 / -0.89 (-6.17%) 02/12/21 MKM Partners Aurora Cannabis downgraded to Sell from Neutral at MKM Partners 02/12/21 Needham Aurora Cannabis downgraded to Underperform from Hold at Needham 02/12/21 Desjardins Aurora Cannabis downgraded to Sell from Hold at Desjardins 02/08/21 CIBC Aurora Cannabis price target raised to C$17 from C$15 at CIBC

2021-02-12 12:40:23

ACB

Aurora Cannabis

$13.54 / -0.89 (-6.17%)

12:40

02/12/21

02/12

12:40

02/12/21

12:40

Aurora Cannabis price target raised to C$14 from C$11 at Canaccord

Canaccord analyst Matt Bottomley raised the firm's price target on Aurora Cannabis to C$14 from C$11 and keeps a Hold rating on the shares.

11
Nov
22
Jan

ACB Aurora Cannabis

$13.54 / -0.89 (-6.17%)

02/12/21 MKM Partners: Aurora Cannabis downgraded to Sell from Neutral at MKM Partners

02/12/21 Needham: Aurora Cannabis downgraded to Underperform from Hold at Needham

02/12/21 Desjardins: Aurora Cannabis downgraded to Sell from Hold at Desjardins

02/08/21 CIBC: Aurora Cannabis price target raised to C$17 from C$15 at CIBC

TODAY'S FREE FLY STORIES

Recommendations	ProsiebenSat price target raised to EUR 27 from EUR 23.50 at JPMorgan » 12:04 04/20/21 04/20 12:04 04/20/21 12:04 PBSFY ProsiebenSat $5.32 / -0.045 (-0.84%) JPMorgan analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PBSFY ProsiebenSat $5.32 / -0.045 (-0.84%) 04/05/21 Goldman Sachs ProsiebenSat price target raised to EUR 23.40 from EUR 19 at Goldman Sachs 03/16/21 Berenberg ProsiebenSat price target raised to EUR 15.10 from EUR 14.50 at Berenberg 03/10/21 JPMorgan ProsiebenSat price target raised to EUR 23.50 from EUR 22.50 at JPMorgan 03/05/21 Barclays ProsiebenSat price target raised to EUR 17.50 from EUR 15 at Barclays
Recommendations	Man Group price target raised to 220 GBp from 185 GBp at JPMorgan » 12:04 04/20/21 04/20 12:04 04/20/21 12:04 MNGPF Man Group $2.20 / + (+0.00%) JPMorgan analyst Gurjit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MNGPF Man Group $2.20 / + (+0.00%) 04/19/21 JPMorgan Man Group price target raised to 185 GBp from 180 GBp at JPMorgan 03/03/21 Citi Man Group price target raised to 175 GBp at Citi 03/03/21 Morgan Stanley Man Group price target raised to 192 GBp from 180 GBp at Morgan Stanley 03/03/21 JPMorgan Man Group price target raised to 180 GBp from 170 GBp at JPMorgan
Earnings	ASM International sees Q2 EUR 390M - EUR 410M » 12:03 04/20/21 04/20 12:03 04/20/21 12:03 ASMIY ASM International $310.74 / -5.68 (-1.80%) Q2 bookings, on a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events ASMIY ASM International $310.74 / -5.68 (-1.80%) 04/16/21 Credit Suisse ASM International price target raised to EUR 315 from EUR 265 at Credit Suisse 04/14/21 Deutsche Bank ASM International price target raised to EUR 300 from EUR 250 at Deutsche Bank 04/14/21 Barclays ASM International price target raised to EUR 295 from EUR 250 at Barclays 03/30/21 Morgan Stanley ASM International price target raised to EUR 240 from EUR 154 at Morgan Stanley ASMIY ASM International $310.74 / -5.68 (-1.80%) 12:02 Today ASM International reports Q1 sales EUR 394M, consensus EUR 392.8M 04/21/21 ASM International - ASMIY
Recommendations	Grand City Properties price target raised to EUR 26 from EUR 24.50 at JPMorgan » 12:03 04/20/21 04/20 12:03 04/20/21 12:03 GRNNF Grand City Properties $26.55 / + (+0.00%) JPMorgan analyst Tim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GRNNF Grand City Properties $26.55 / + (+0.00%) 03/16/21 Deutsche Bank Grand City Properties price target lowered to EUR 23 at Deutsche Bank 02/01/21 Barclays Grand City Properties upgraded to Overweight from Equal Weight at Barclays 12/07/20 HSBC Grand City Properties downgraded to Hold from Buy at HSBC 11/19/20 Jefferies Grand City Properties price target raised to EUR 22 from EUR 20 at Jefferies
Earnings	ASM International reports Q1 sales EUR 394M, consensus EUR 392.8M » 12:02 04/20/21 04/20 12:02 04/20/21 12:02 ASMIY ASM International $310.74 / -5.68 (-1.80%) Reports Q1 operating… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events ASMIY ASM International $310.74 / -5.68 (-1.80%) 04/16/21 Credit Suisse ASM International price target raised to EUR 315 from EUR 265 at Credit Suisse 04/14/21 Deutsche Bank ASM International price target raised to EUR 300 from EUR 250 at Deutsche Bank 04/14/21 Barclays ASM International price target raised to EUR 295 from EUR 250 at Barclays 03/30/21 Morgan Stanley ASM International price target raised to EUR 240 from EUR 154 at Morgan Stanley 04/21/21 ASM International - ASMIY

Recommendations	British Land price target raised to 550 GBp from 500 GBp at JPMorgan » 12:02 04/20/21 04/20 12:02 04/20/21 12:02 BTLCY British Land $7.27 / +0.17 (+2.39%) JPMorgan analyst Neil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BTLCY British Land $7.27 / +0.17 (+2.39%) 04/08/21 UBS British Land price target raised to 560 GBp from 520 GBp at UBS 01/21/21 Deutsche Bank British Land upgraded to Buy from Hold at Deutsche Bank 01/15/21 JPMorgan British Land price target raised to 500 GBp from 430 GBp at JPMorgan 01/14/21 RBC Capital British Land downgraded to Underperform from Sector Perform at RBC Capital
Recommendations	Brenntag price target raised to EUR 82 from EUR 75 at JPMorgan » 12:02 04/20/21 04/20 12:02 04/20/21 12:02 BNTGY Brenntag $18.22 / -0.2 (-1.09%) JPMorgan analyst Chetan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BNTGY Brenntag $18.22 / -0.2 (-1.09%) 03/16/21 DZ Bank Brenntag downgraded to Sell from Hold at DZ Bank 03/15/21 JPMorgan Brenntag price target raised to EUR 75 from EUR 72.50 at JPMorgan 03/11/21 Credit Suisse Brenntag price target raised to EUR 85.50 from EUR 83 at Credit Suisse 02/22/21 Credit Suisse Brenntag price target raised to EUR 83 from EUR 78 at Credit Suisse
Recommendations	BMW price target raised to EUR 90 from EUR 85 at JPMorgan » 12:01 04/20/21 04/20 12:01 04/20/21 12:01 BMWYY BMW $35.40 / + (+0.00%) JPMorgan analyst Jose… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals BMWYY BMW $35.40 / + (+0.00%) 03/18/21 U.K. cuts electric vehicle grants, Tesla Model 3 no longer covered 01/27/21 BMW reports Q4 automotive free cash flow above market expectations 12/08/20 AWS, BMW announce strategic collaboration 11/18/20 BMW to invest EUR400M in new vehicle assembly at main plant in Munich BMWYY BMW $35.40 / + (+0.00%) 04/12/21 Exane BNP Paribas BMW upgraded to Outperform from Neutral at Exane BNP Paribas 04/01/21 Deutsche Bank BMW upgraded to Buy from Hold at Deutsche Bank 03/29/21 Jefferies BMW upgraded to Buy from Hold at Jefferies 03/24/21 RBC Capital BMW price target raised to EUR 86 from EUR 79 at RBC Capital BMWYY BMW $35.40 / + (+0.00%) 04/19/21 BMW says preliminary 'key' performance figures for Q1 top market expectations BMWYY BMW $35.40 / + (+0.00%) 03/22/21 California senators urge Biden to set end date for gas car sales, Reuters report 03/17/21 BMW does not plan to make its own EV batteries, CNBC reports 03/02/21 IPG Mediabrands planning event focused on Black-owned media firms, AdAge says 02/01/21 Tesla stands to get at least EUR1B in German subsidies, Reuters reports
Hot Stocks	SOS Limited enters into purchase agreement for 575 cryptocurrency mining rigs » 12:01 04/20/21 04/20 12:01 04/20/21 12:01 SOS SOS Limited $3.59 / -0.4 (-10.03%) SOS Limited announced hat… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options SOS SOS Limited $3.59 / -0.4 (-10.03%) 04/16/21 SOS Limited falls -6.8% 04/16/21 SOS Limited falls -8.2% 04/14/21 SOS Limited receives third batch of crypto minings rigs 04/12/21 SOS Limited unit to acquire majority interest in three US-based power plants SOS SOS Limited $3.59 / -0.4 (-10.03%) 04/13/21 Short seller Culper says SOS Limited appears to be under SEC investigation 03/03/21 SOS rallies after Scorpio questions shorts, gives stock $40 valuation SOS SOS Limited $3.59 / -0.4 (-10.03%) 03/09/21 Short-seller Culper says SOS 'admits' to not purchasing claimed bitcoin miners SOS SOS Limited $3.59 / -0.4 (-10.03%) 04/16/21 Largest borrow rate increases among liquid names 04/14/21 Largest borrow rate increases among liquid names 04/08/21 Notable open interest changes for April 8th 03/31/21 Notable open interest changes for March 31st
Hot Stocks	dMY Technology II falls -11.6% » 12:00 04/20/21 04/20 12:00 04/20/21 12:00 DMYD dMY Technology II $16.13 / -2.125 (-11.64%) dMY Technology II is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Options DMYD dMY Technology II $16.13 / -2.125 (-11.64%) 04/05/21 dMY Technology II rises 37.7% 04/05/21 dMY Technology II rises 32.6% 04/05/21 dMY Technology II rises 23.4% 03/29/21 dMY Technology II sets meeting date to approve combination with Genius Sports DMYD dMY Technology II $16.13 / -2.125 (-11.64%) 04/07/21 Craig-Hallum Craig-Hallum sees Genius as 'a clear winner' after NY online sports betting news 04/05/21 Craig-Hallum Genius Sports price target raised to $30 from $25 at Craig-Hallum 02/25/21 B. Riley Securities B. Riley starts dMY at Buy as better way to invest in sports betting 02/24/21 B. Riley Securities dMY Technology II initiated with a Buy at B. Riley Securities DMYD dMY Technology II $16.13 / -2.125 (-11.64%) 04/01/21 Genius Sports, NFL sign multi-year data rights deal, CNBC reports 01/28/21 FanDuel, Genius Sports to collaborate on marketing initiative, IGB reports DMYD dMY Technology II $16.13 / -2.125 (-11.64%) 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Fly Intel: Wall Street's top stories at midday 04/01/21 Fly Intel: After-Hours Movers 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart DMYD dMY Technology II $16.13 / -2.125 (-11.64%) 04/07/21 Largest borrow rate increases among liquid names 03/11/21 Largest borrow rate increases among liquid names

Hot Stocks	China Green falls -24.7% » 12:00 04/20/21 04/20 12:00 04/20/21 12:00 CGA China Green $12.60 / -4.155 (-24.80%) China Green is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News CGA China Green $12.60 / -4.155 (-24.80%) 10:00 Today China Green falls -13.3% 09:47 Today China Green falls -9.3% 04/19/21 China Green rises 9.1% 04/16/21 China Green rises 10.6%
Hot Stocks	Companhia Brasileira de Distribuicao rises 7.9% » 12:00 04/20/21 04/20 12:00 04/20/21 12:00 CBD Companhia Brasileira de Distribuicao $6.99 / +0.51 (+7.87%) Companhia Brasileira de… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CBD Companhia Brasileira de Distribuicao $6.99 / +0.51 (+7.87%) 04/13/21 Companhia Brasileira de Distribuicao rises 7.6% 04/12/21 Companhia Brasileira de Distribuicao rises 8.5% 03/08/21 Companhia Brasileira de Distribuicao falls -17.5% 03/08/21 Companhia Brasileira de Distribuicao falls -13.5% CBD Companhia Brasileira de Distribuicao $6.99 / +0.51 (+7.87%) 04/15/21 BofA Companhia Brasileira de Distribuicao downgraded to Neutral from Buy at BofA 03/02/21 Goldman Sachs Brasileira de Distribuicao downgraded to Neutral from Buy at Goldman Sachs
Hot Stocks	San Juan Basin Royalty Trust rises 8.3% » 12:00 04/20/21 04/20 12:00 04/20/21 12:00 SJT San Juan Basin Royalty Trust $4.70 / +0.36 (+8.29%) San Juan Basin Royalty… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News SJT San Juan Basin Royalty Trust $4.70 / +0.36 (+8.29%) 10:00 Today San Juan Basin Royalty Trust rises 9.6% 02/24/21 San Juan Basin Royalty Trust announces Hilcorp's 2021 capital plan
Hot Stocks	Kansas City Southern rises 16.0% » 12:00 04/20/21 04/20 12:00 04/20/21 12:00 KSU Kansas City Southern $297.40 / +41.07 (+16.02%) Kansas City Southern is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KSU Kansas City Southern $297.40 / +41.07 (+16.02%) 10:00 Today Kansas City Southern rises 14.5% 09:47 Today Kansas City Southern rises 14.2% 07:22 Today CN: Cash portion of deal to be funded thorugh cash on hand, $19.3B of new debt 07:19 Today Canadian National makes 'superior' proposal to combine with Kansas City Southern KSU Kansas City Southern $297.40 / +41.07 (+16.02%) 04/19/21 Raymond James Kansas City Southern downgraded to Outperform from Strong Buy at Raymond James 04/19/21 Raymond James Kansas City Southern downgraded to Outperform from Strong Buy at Raymond James 04/15/21 Fly Intel: Top five analyst downgrades 04/15/21 Wells Fargo Kansas City Southern downgraded to Equal Weight from Overweight at Wells Fargo KSU Kansas City Southern $297.40 / +41.07 (+16.02%) 04/16/21 Kansas City Southern reports Q1 EPS $1.68, consensus $1.94 01/22/21 Kansas City Southern sees FY22 EPS $10.50-$11.00 01/22/21 Kansas City Southern sees FY21 EPS at least $9.00, consensus $8.51 01/22/21 Kansas City Southern reports Q4 EPS $1.80, consensus $1.92 KSU Kansas City Southern $297.40 / +41.07 (+16.02%) 11/10/20 Kansas City Southern potential bidders have moved on, CNBC reports KSU Kansas City Southern $297.40 / +41.07 (+16.02%) 08:56 Today Fly Intel: Pre-market Movers 03/22/21 Fly Intel: Wall Street's top stories for Monday 03/22/21 Fly Intel: Wall Street's top stories at midday 03/22/21 Fly Intel: Pre-market Movers 05/20/21 Kansas City Southern KSU Kansas City Southern $297.40 / +41.07 (+16.02%) 09:55 Today Early notable gainers among liquid option names on April 20th 03/22/21 Early notable gainers among liquid option names on March 22nd
Earnings	Zalando sees Q1 results above estimates on strong spring-summer start » 11:58 04/20/21 04/20 11:58 04/20/21 11:58 ZLNDY Zalando $54.46 / -0.455 (-0.83%) Zalando expects Q1… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ZLNDY Zalando $54.46 / -0.455 (-0.83%) 03/18/21 JPMorgan Zalando price target raised to EUR 95 from EUR 81 at JPMorgan 03/17/21 Barclays Zalando price target raised to EUR 110 from EUR 105 at Barclays 03/17/21 Morgan Stanley Zalando price target raised to EUR 85 from EUR 82 at Morgan Stanley 03/17/21 Societe Generale Zalando price target raised to EUR 110 from EUR 102 at Societe Generale

Hot Stocks	J&J resumes COVID-19 vaccine roll-out in Europe following EMA review » 11:57 04/20/21 04/20 11:57 04/20/21 11:57 JNJ Johnson & Johnson $166.89 / +4.08 (+2.51%) Johnson & Johnson… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $166.89 / +4.08 (+2.51%) 10:15 Today EMA recommends clot warning for J&J vaccine, says benefit still positive 10:11 Today EMA says 'overall benefit-risk remains positive' for J&J Covid vaccine 10:09 Today EMA says blood clot warning should be added to J&J Covid vaccine 09:37 Today Johnson & Johnson says 'cautiously hopeful' on path forward for COVID vaccine JNJ Johnson & Johnson $166.89 / +4.08 (+2.51%) 04/19/21 Chardan Chardan sees J&J moving forward with Emergent if observations are minor 04/14/21 Guggenheim Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim 04/13/21 Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers JNJ Johnson & Johnson $166.89 / +4.08 (+2.51%) 06:37 Today Johnson & Johnson raises FY21 adjusted EPS view to $9.30-$9.45 from $9.25-$9.45 06:32 Today Johnson & Johnson reports Q1 adjusted EPS 2.59, consensus $2.34 04/19/21 Notable companies reporting before tomorrow's open 04/19/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $166.89 / +4.08 (+2.51%) 06:25 Today California lawyer accuses drugmakers of causing opioid addiction, WSJ reports 04/19/21 J&J affirms 100M vaccine commitment in U.S. to CNBC 04/19/21 J&J COVID-19 vaccine paused, concerns of mistreating blood clots, WSJ reports 04/18/21 Fauci predicts resumption of J&J COVID vaccine use, Reuters reports JNJ Johnson & Johnson $166.89 / +4.08 (+2.51%) 04/16/21 Fly Intel: Wall Street's top stories for Friday 04/16/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 08:30 Today Johnson & Johnson - JNJ 04/22/21 Johnson & Johnson JNJ Johnson & Johnson $166.89 / +4.08 (+2.51%) 04/13/21 Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th
Conference/Events	Truist medical tech analysts to hold an analyst/industry conference call » 11:55 04/20/21 04/20 11:55 04/20/21 11:55 Medical Technology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Jazz Pharmaceuticals to host conference call » 11:55 04/20/21 04/20 11:55 04/20/21 11:55 JAZZ Jazz Pharmaceuticals $164.35 / -2.81 (-1.68%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events JAZZ Jazz Pharmaceuticals $164.35 / -2.81 (-1.68%) 07:46 Today Jazz Pharma announces results from Phase 3 study of XywavTM oral solution 04/12/21 Jazz Pharmaceuticals: FDA grants Priority Review of sNDA for Xywav 04/01/21 Lava Therapeutics appoints Karen Wilson to board of directors 03/30/21 Jazz announces FDA approved revised label for Vyxeos JAZZ Jazz Pharmaceuticals $164.35 / -2.81 (-1.68%) 04/14/21 Stifel Jazz Pharmaceuticals price target raised to $202 from $195 at Stifel 04/06/21 RBC Capital Jazz Pharmaceuticals transferred with an Outperform at RBC Capital 04/01/21 Morgan Stanley Jazz Pharmaceuticals price target raised to $176 from $162 at Morgan Stanley 03/01/21 UBS Jazz Pharmaceuticals price target raised to $228 from $174 at UBS JAZZ Jazz Pharmaceuticals $164.35 / -2.81 (-1.68%) 02/23/21 Jazz Pharmaceuticals sees FY21 adjusted EPS $15.65-$16.85, consensus $16.78 02/23/21 Jazz Pharmaceuticals reports Q4 EPS $4.00, consensus $4.20 02/16/21 GW Pharmaceuticals reports Q4 EPS (8c), consensus (60c) 11/02/20 Jazz Pharma narrows FY20 non-GAAP EPS view to $12.20-$13.00 from $11.90-$13.00 JAZZ Jazz Pharmaceuticals $164.35 / -2.81 (-1.68%) 04/05/21 'Failure is the new winning' for Jazz Pharmaceuticals, FFJ says JAZZ Jazz Pharmaceuticals $164.35 / -2.81 (-1.68%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Healthcare Virtual Conference 2021 12:30 Today Jazz Pharmaceuticals - JAZZ 05/04/21 Jazz Pharmaceuticals - JAZZ 08/12/21 PDFUA Date for Xywav
Periodicals	Tesla plans launch of self-inspection, rectify service in China, Reuters reports 11:50 04/20/21 04/20 11:50 04/20/21 11:50 TSLA Tesla $712.96 / -1.57 (-0.22%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TSLA Tesla $712.96 / -1.57 (-0.22%) 04/19/21 Tesla CEO claims data logs show Autopilot not enabled in fatal Texas crash 04/18/21 Fly Intel: Top five weekend stock stories 04/17/21 Tesla CEO sees 'limited production of Model Y this year' at 'Giga Texas' factory 04/16/21 EU passenger car registrations up 87.3% in March, up 3.2% in Q1 TSLA Tesla $712.96 / -1.57 (-0.22%) 07:18 Today Mizuho Tesla price target raised to $820 from $775 at Mizuho 04/13/21 Credit Suisse Credit Suisse ahead of consensus into Q1 EPS for Tesla 04/12/21 Fly Intel: Top five analyst upgrades 04/12/21 Canaccord Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem TSLA Tesla $712.96 / -1.57 (-0.22%) 01/27/21 Tesla reports Q4 non-GAAP EPS 80c, consensus $1.01 01/27/21 Notable companies reporting after market close 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close TSLA Tesla $712.96 / -1.57 (-0.22%) 06:02 Today Tesla working on vehicles tailored to China, TechCrunch reports 04/19/21 NHTSA sending team to probe fatal Tesla crash with no driver, AP reports 04/19/21 NHTSA opens probe of crash of Tesla vehicle near Houston, Bloomberg says 04/18/21 Tesla crash in Texas believed to be driverless, WSJ reports TSLA Tesla $712.96 / -1.57 (-0.22%) 04/19/21 Fly Intel: Wall Street's top stories for Monday 04/19/21 Charged: Walmart invests in GM-backed self-driving company Cruise 04/19/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Charged: White House proposal calling for $100B in new EV consumer rebates 04/26/21 Tesla - TSLA TSLA Tesla $712.96 / -1.57 (-0.22%) 04/19/21 Notable open interest changes for April 19th 04/15/21 Notable open interest changes for April 15th 04/14/21 Notable open interest changes for April 14th 04/13/21 Early notable gainers among liquid option names on April 13th
Recommendations	Carl Zeiss Meditec price target raised to EUR 170 from EUR 150 at Deutsche Bank » 11:48 04/20/21 04/20 11:48 04/20/21 11:48 CZMWY Carl Zeiss Meditec $176.00 / -0.75 (-0.42%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CZMWY Carl Zeiss Meditec $176.00 / -0.75 (-0.42%) 04/16/21 Kepler Cheuvreux Carl Zeiss upgraded to Hold on faster recovery at Kepler Cheuvreux 04/16/21 Kepler Cheuvreux Carl Zeiss Meditec upgraded to Hold from Reduce at Kepler Cheuvreux 02/16/21 Commerzbank Carl Zeiss Meditec upgraded to Hold from Reduce at Commerzbank 02/09/21 Deutsche Bank Carl Zeiss Meditec price target raised to EUR 150 from EUR 140 at Deutsche Bank

Earnings	Kering reports Q1 revenue EUR 3.89B, consensus EUR 3.58B » 11:47 04/20/21 04/20 11:47 04/20/21 11:47 PPRUY Kering $77.05 / +0.9 (+1.18%) Gucci posted revenue of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals PPRUY Kering $77.05 / +0.9 (+1.18%) 04/07/21 Deutsche Bank Kering price target raised to EUR 590 from EUR 580 at Deutsche Bank 03/30/21 UBS Kering price target raised to EUR 590 from EUR 585 at UBS 03/15/21 UBS Kering price target raised to EUR 585 from EUR 568 at UBS 03/15/21 Deutsche Bank Kering price target raised to EUR 580 from EUR 544 at Deutsche Bank PPRUY Kering $77.05 / +0.9 (+1.18%) 03/04/21 Kering rumored to be 'mystery suitor' eyeing Ralph Lauren, Betaville says
Options	Wal-Mart call volume above normal and directionally bullish » 11:45 04/20/21 04/20 11:45 04/20/21 11:45 WMT Walmart $141.08 / +1.4 (+1.00%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WMT Walmart $141.08 / +1.4 (+1.00%) 06:49 Today Velodyne Lidar signs multi-year sales agreement with Gatik 05:50 Today U.K.'s CMA: Bellis' purchase of Asda raises some competition concerns 04/19/21 Walmart adds the BinaxNOW COVID-19 Antigen Self Test 04/19/21 Abbott begins shipping BinaxNOW COVID-19 Ag Self Test to retailers WMT Walmart $141.08 / +1.4 (+1.00%) 04/06/21 Morgan Stanley Walmart+ membership 'seems to have stagnated,' says Morgan Stanley 03/16/21 MKM Partners Walmart price target lowered to $141 from $154 at MKM Partners 02/23/21 Evercore ISI Walmart accelerating change with investments, says Evercore ISI 02/19/21 Morgan Stanley Walmart terminal value rising with investments, says Morgan Stanley WMT Walmart $141.08 / +1.4 (+1.00%) 02/18/21 Walmart reports Q4 adjusted EPS $1.39, consensus $1.51 02/17/21 Notable companies reporting before tomorrow's open 02/17/21 Notable companies reporting before tomorrow's open 11/17/20 Walmart reports Q3 adjusted EPS $1.34, consensus $1.18 WMT Walmart $141.08 / +1.4 (+1.00%) 04/13/21 Walmart compliance chief leaving company, WSJ reports 04/13/21 Walmart chief ethics and compliance officer leaving company, WSJ says 04/09/21 McDonald's closing 'hundreds' of restaurants inside Walmart, WSJ reports 04/06/21 Walmart's Flipkart aiming for IPO in Q4, Bloomberg says WMT Walmart $141.08 / +1.4 (+1.00%) 04/19/21 Charged: Walmart invests in GM-backed self-driving company Cruise 04/19/21 Vizio rises as Wall Street analysts roll out bullish coverage 03/17/21 Street Fight: Analysts diverge on Plug following financial restatement news 03/10/21 Fly Intel: What to watch in Oracle's earnings report 06/02/21 Wal-Mart Stores, Inc. WMT Walmart $141.08 / +1.4 (+1.00%) 04/06/21 Wal-Mart call volume above normal and directionally bullish 04/05/21 Unusually active option classes on open April 5th 03/29/21 Unusually active option classes on open March 29th 03/25/21 Wal-Mart call volume above normal and directionally bullish
Periodicals	Microsoft working on new Store app for Windows 10, Windows Central says » 11:42 04/20/21 04/20 11:42 04/20/21 11:42 MSFT Microsoft $257.48 / -1.42 (-0.55%) Microsoft is developing a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT Microsoft $257.48 / -1.42 (-0.55%) 04/19/21 Microsoft to start testing cloud gaming for Windows 10 PCs, iOS devices 04/16/21 New 'Monster Hunter: Rise' was March's 2nd best-selling game in U.S., says NPD 04/16/21 Video game spending grew 18% y/y to $5.6B in March, says NPD 04/13/21 Microsoft issues patch for on-premise Exchange Servers after NSA tip MSFT Microsoft $257.48 / -1.42 (-0.55%) 04/19/21 Morgan Stanley Morgan Stanley reiterates Microsoft as a Top Pick ahead of earnings 04/13/21 Morgan Stanley Morgan Stanley says Microsoft 'uniquely positioned' for synergies with Nuance 04/13/21 Craig-Hallum Nuance downgraded to Hold from Buy at Craig-Hallum 04/13/21 Wedbush Nuance downgraded to Neutral at Wedbush on Microsoft deal MSFT Microsoft $257.48 / -1.42 (-0.55%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B MSFT Microsoft $257.48 / -1.42 (-0.55%) 04/13/21 CD Projekt CEO tells Reuters no plans to shelve 'Cyberpunk 2077' 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says 04/09/21 Hackers scraped data of 500M LinkedIn users, Insider reports 04/06/21 Facebook, Apple and Niantic see a future in augmented -reality glasses, WSJ says MSFT Microsoft $257.48 / -1.42 (-0.55%) 04/13/21 Game On: GameStop may be looking for new CEO 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 05/24/21 Global Technology, Media & Communications Virtual Conference 04/27/21 Microsoft - MSFT MSFT Microsoft $257.48 / -1.42 (-0.55%) 04/06/21 Microsoft call buyer realizes 130% same-day gains 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th
Periodicals	Danske Bank falls after Borsen report of U.S. civil lawsuit » 11:41 04/20/21 04/20 11:41 04/20/21 11:41 DNKEY Danske Bank $9.85 / -0.16 (-1.60%) Shares of Danske Bank are… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research DNKEY Danske Bank $9.85 / -0.16 (-1.60%) 04/13/21 Deutsche Bank Danske Bank price target raised to DKK 127 from DKK 120 at Deutsche Bank 04/12/21 Barclays Danske Bank price target raised to DKK 125 from DKK 114 at Barclays 04/12/21 UBS Danske Bank price target raised to DKK 150 from DKK 143 at UBS 02/09/21 Barclays Danske Bank price target raised to DKK 114 from DKK 105 at Barclays
Hot Stocks	Kazia Therapeutics expands pipeline to include EVT801 » 11:40 04/20/21 04/20 11:40 04/20/21 11:40 KZIA Kazia Therapeutics $10.61 / -0.38 (-3.46%) , EVTCY Evotec $80.15 / + (+0.00%) , SNY Sanofi $51.78 / -0.08 (-0.15%) Kazia (KZIA) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KZIA EVTCY SNY KZIA Kazia Therapeutics $10.61 / -0.38 (-3.46%) 04/15/21 Kazia Therapeutics trading halted, news pending 03/01/21 Kazia Therapeutics licenses Cantrixil to Oasmia 12/10/20 Kazia Therapeutics to collaborate with PNOC for paxalisib combination study 12/09/20 Kazia Therapeutics reports topline data from Cantrixil Phase 1 study EVTCY Evotec $80.15 / + (+0.00%) 03/01/21 Chinook Therapeutics, Evotec enter collaboration for chronic kidney diseases 01/05/21 Evotec receives $6M from Bristol-Myers for neuroscience partnership 12/17/20 Evotec achieves milestones in Bristol-Myers pact in targeted protein degradation SNY Sanofi $51.78 / -0.08 (-0.15%) 04/19/21 Sanofi says EC approves second indication of Sarclisa for relapsed MM 04/19/21 Translate Bio announces preclinical results for COVID-19 vaccine candidate 04/16/21 Sanofi completes acquisition of Kiadis Pharma 04/12/21 Sanofi to invest EUR 400M in vaccine production site in Singapore KZIA EVTCY SNY KZIA Kazia Therapeutics $10.61 / -0.38 (-3.46%) 01/05/21 H.C. Wainwright Kazia Therapeutics initiated with a Buy at H.C. Wainwright EVTCY Evotec $80.15 / + (+0.00%) 03/05/21 Citi Evotec downgraded to Neutral from Buy at Citi 01/28/21 RBC Capital Evotec downgraded to Sector Perform from Outperform at RBC Capital 01/19/21 Deutsche Bank Evotec downgraded to Hold from Buy at Deutsche Bank 11/20/20 RBC Capital Evotec price target raised to EUR 32 from EUR 30 at RBC Capital SNY Sanofi $51.78 / -0.08 (-0.15%) 04/06/21 Barclays Sanofi price target raised to EUR 85 from EUR 80 at Barclays 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/10/21 Morgan Stanley Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley 02/05/21 Piper Sandler Piper reiterates Overweight on Kymera after Sanofi capital markets day SNY SNY Sanofi $51.78 / -0.08 (-0.15%) 02/05/21 Sanofi reports Q4 business EPS EUR 1.22, flat vs. last year 10/29/20 Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year SNY SNY Sanofi $51.78 / -0.08 (-0.15%) 03/15/21 BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports 02/15/21 CEO says Sanofi mRNA vaccine won't be ready this year, Bloomberg reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports SNY SNY Sanofi $51.78 / -0.08 (-0.15%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 04/28/21 Sanofi - SNY 05/18/21 PDUFA Date for Avalglucosidase Alfa KZIA KZIA Kazia Therapeutics $10.61 / -0.38 (-3.46%) 11/25/20 new option listings on November 25th

Events

Earnings calls, analyst events, roadshows and more

JAZZ
Today at 12:30

Jazz Pharmaceuticals - JAZZ Conference Calls
MSGM
Today at 13:00

Motorsport Games - MSGM Conference Calls
AAPL
Today at 13:00

Apple Firm Sponsored Meetings

Apple Park, Cupertino, CA
IDYA
Today at 13:00

IDEAYA Biosciences, Inc. Firm Sponsored Meetings
CNXC
Today at 13:00

Concentrix Corporation Firm Sponsored Meetings
PEG
Today at 13:00

Public Service Enterprise Group Firm Sponsored Meetings
IDYA
Today at 13:00

Ideaya Biosciences Firm Sponsored Meetings

Virtual Meeting
Today at 13:00

Leisure/Gaming Industry Meetings
Today at 13:00

Medical Technology Industry Meetings
VOLT
Today at 13:30

Volt Information Sciences Inc. Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	IFBD X IFBD Infobird IPO Managers: WestPark Capital Priced at: $4.00 6.25M Shares
Tues	TRKA X TRKA Troika Media IPO Managers: Kingswood Priced at: $4.15 5.78M Shares
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley $82.50-83.00 6.1M Shares
Tues	DV X DV DoubleVerify IPO Managers: Goldman Sachs & JPMorgan, Barclays, RBC Capital, Truist, William Blair, KeyBanc, Canaccord, JMP Securities, Needham, Loop Capital, Capital One $24.00-27.00 13.3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NPCE X NPCE NeuroPace IPO Managers: JPMorgan & Morgan Stanley, Wells Fargo, SVB Leerink $15.00-17.00 5.31M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PATH X PATH UiPath IPO Managers: Morgan Stanley & JPMorgan, BofA, Credit Suisse, Barclays, Wells Fargo, SMBC Nikko, BMO Capital, MIZU, KeyBanc, TD Securities, Truist, Cowen, Evercore ISI, Macquarie, Nomura, RBC Capital, Canaccord, DA Davidson, Oppenheimer, Needham $43.00-50.00 23.89M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SKYT X SKYT SkyWater Technology IPO Managers: Jefferies & Cowen, Piper Sandler $12.00-14.00 5.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FUTU X FUTU Futu Holdings Secondary Managers: BofA & Haitong $177.92 9.5M Shares ZLAB X ZLAB Zai Lab Secondary Managers: JPMorgan, Goldman Sachs, Jefferies, Citi, SVB Leerink & Guggenheim $164.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	KNBE X KNBE KnowBe4 IPO Managers: Morgan Stanley, Goldman Sachs, BofA & KKR $16.00-18.00 11.819M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZY X ZY Zymergen IPO Managers: JPMorgan & Goldman Sachs, BofA, UBS, LAZA $28.00-31.00 13.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AGTI X AGTI Agiliti IPO Managers: BofA, Goldman Sachs, Morgan Stanley & BMO Capital, Citi, JEFF< UBSW, KeyBanc, Raymond James, MUFG, SMBC Nikko, MISC, SIEB $18.00-20.00 26.316M Shares IMPL X IMPL Impel NeuroPharma IPO Managers: Cowen & Guggenheim, Wedbush $14.00-16.00 5.33M Shares RAIN X RAIN Rain Therapeutics IPO Managers: Goldman Sachs, Citi, Piper Sandler & Guggenheim $16.00-18.00 7.353M Shares SWIM X SWIM Latham Group IPO Managers: Barclays, BofA, Morgan Stanley & Goldman Sachs, Nomura, William Blair, Baird, KeyBanc, Truist $19.00-21.00 20M Shares TMCI X TMCI Treace Medical IPO Managers: JPMorgan & Morgan Stanley, SVB Leerink, Stifel $15.00-17.00 9.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Aurora Cannabis price target raised to C$14 from C$11 at Canaccord

TODAY'S FREE FLY STORIES

Get Full Fly Access